Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia
Background: Helicobacter pylori antimicrobial resistance rates differ among countries and even between different areas of a country. In Colombia, the most commonly used antimicrobials for the treatment of H pylori infection are amoxicillin, clarithromycin and metronidazole. Aim: To determine antimic...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2009
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001000005 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872009001000005 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720090010000052009-12-02Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en ColombiaÁlvarez,AdalucyMoncayo,José IgnacioSantacruz,Jorge JavierCorredor,Luisa FernandaReinosa,ElizabethMartínez,José WilliamBeltrán,Leonardo Antibacterial agents Helicobacter pylori Metronidazole Background: Helicobacter pylori antimicrobial resistance rates differ among countries and even between different areas of a country. In Colombia, the most commonly used antimicrobials for the treatment of H pylori infection are amoxicillin, clarithromycin and metronidazole. Aim: To determine antimicrobial susceptibility of H pylori strains isolated in Colombia. Materials and methods: Eighty eight strains of H pylori were isolated and identified by microbiological methods and confirmed with polymerase chain reaction (PCR). The detection of antimicrobial resistance to amoxicillin, clarithromycin, metronidazole and tetraclycline, was conducted by the Etest method. Mutations in the 23S rDNA, involved in resistance to clarithromycin, were detected using PCR and restriction fragment lenght polymorphism. Results: Eighty eight and 2.2% of the strains were resistant to metronidazole and clarithromycin, respectively. No isolate was simultaneously resistant to amoxicillin or tetracycline. The two clarithromycin resistant strains were homozygous for the A2143G mutation. No mutations were found in the remaining 86 susceptible strains. Conclusions: The high rate of metronidazole resistance in our population precludes the use of this drug for the empirical treatment of Hpylori infection.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.137 n.10 20092009-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001000005es10.4067/S0034-98872009001000005 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Antibacterial agents Helicobacter pylori Metronidazole |
spellingShingle |
Antibacterial agents Helicobacter pylori Metronidazole Álvarez,Adalucy Moncayo,José Ignacio Santacruz,Jorge Javier Corredor,Luisa Fernanda Reinosa,Elizabeth Martínez,José William Beltrán,Leonardo Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia |
description |
Background: Helicobacter pylori antimicrobial resistance rates differ among countries and even between different areas of a country. In Colombia, the most commonly used antimicrobials for the treatment of H pylori infection are amoxicillin, clarithromycin and metronidazole. Aim: To determine antimicrobial susceptibility of H pylori strains isolated in Colombia. Materials and methods: Eighty eight strains of H pylori were isolated and identified by microbiological methods and confirmed with polymerase chain reaction (PCR). The detection of antimicrobial resistance to amoxicillin, clarithromycin, metronidazole and tetraclycline, was conducted by the Etest method. Mutations in the 23S rDNA, involved in resistance to clarithromycin, were detected using PCR and restriction fragment lenght polymorphism. Results: Eighty eight and 2.2% of the strains were resistant to metronidazole and clarithromycin, respectively. No isolate was simultaneously resistant to amoxicillin or tetracycline. The two clarithromycin resistant strains were homozygous for the A2143G mutation. No mutations were found in the remaining 86 susceptible strains. Conclusions: The high rate of metronidazole resistance in our population precludes the use of this drug for the empirical treatment of Hpylori infection. |
author |
Álvarez,Adalucy Moncayo,José Ignacio Santacruz,Jorge Javier Corredor,Luisa Fernanda Reinosa,Elizabeth Martínez,José William Beltrán,Leonardo |
author_facet |
Álvarez,Adalucy Moncayo,José Ignacio Santacruz,Jorge Javier Corredor,Luisa Fernanda Reinosa,Elizabeth Martínez,José William Beltrán,Leonardo |
author_sort |
Álvarez,Adalucy |
title |
Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia |
title_short |
Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia |
title_full |
Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia |
title_fullStr |
Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia |
title_full_unstemmed |
Resistencia a metronidazol y claritromicina en aislamientos de Helicobacter pylori de pacientes dispépticos en Colombia |
title_sort |
resistencia a metronidazol y claritromicina en aislamientos de helicobacter pylori de pacientes dispépticos en colombia |
publisher |
Sociedad Médica de Santiago |
publishDate |
2009 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872009001000005 |
work_keys_str_mv |
AT alvarezadalucy resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia AT moncayojoseignacio resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia AT santacruzjorgejavier resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia AT corredorluisafernanda resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia AT reinosaelizabeth resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia AT martinezjosewilliam resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia AT beltranleonardo resistenciaametronidazolyclaritromicinaenaislamientosdehelicobacterpyloridepacientesdispepticosencolombia |
_version_ |
1718436468124286976 |